Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin α2β1

Blood

Volumn 102, Issue 6, 2003, Pages 2085-2092

  Lahav, Judith ^a   Wijnen, Eveline M ^b   Hess, Oded ^b   Hamaia, Samir W ^b   Griffiths, Delia ^b   Makris, Michael ^b   Knight, C Graham ^b   Essex, David W ^b   Farndale, Richard W ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2BBETA3 INTEGRIN; COLLAGEN; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN; GLYCOPROTEIN VI; INTEGRIN; INTEGRIN RECEPTOR; PROTEIN DISULFIDE ISOMERASE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR BINDING; THROMBOCYTE ADHESION;

EID: 0141567629     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1646     Document Type: Article

References (65)

1. Shattif SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91: 2645-2657.
2. Yan B, Hu D-D, Knowles SK, Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet integrin αIIbβ3. J Biol Chem. 2000;275:7249-7260.
3. Niewiarowski S, Kornecki E, Hershock D, et al. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa. J Lab Clin Med. 1985;106:651-660.
4. Sun Q-H, Liu C-Y, Wang R, Paddock CM, Newman PJ. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (αIIbβ3) integrin complexes. 2002;100:2094-2101.
5. Si-Tahar M, Pidard D, Balloy V, et al. Human neutrophil elastase proteolytically activates the platelet integrin αIIbβ3 through cleavage of the carboxyl terminus of the αIIb subunit heavy chain: involvement in the potentiation of platelet aggregation. J Biol Chem. 1997;272:11636-11647.
6. Chen P, Melchior C, Brons NHC, Schlegel N, Caen J, Kieffer N. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in αIIbβ3 activation. J Biol Chem. 2001;276:38628-38635.
7. Ruiz C, Liu C-Y, Sun Q-H, et al. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (αIIbβ3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Blood. 2001;98:2432-2441.
8. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA. An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci U S A. 2001;98:2387-2392.
9. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci U S A. 2001;98:2393-2398.
10. Gofer-Dadosh N, Klepfish A, Schmilowitz H, Shaklai M, Lahav J. Affinity modulation in platelet α2β1 following ligand binding. Biochem Biophys Res Commun. 1997;232:724-727.
11. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett. 2000;475:89-92.
12. Lahav J, Jurk K, Hess O, et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood. 2002;100:2472-2478.
13. Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost. 2002;84:891-896.
14. Hoffmann C, Moro S, Nicholas RA, Harden TK, Jacobson KA. The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem. 1999;274:14639-14647.
15. Ding Z, Kim S, Dorsam RT, Jin J, Kunapuli SP. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood. 2003;101;3908-3914.
16. O'Neill S, Robinson A, Deering A, Ryan M, Fitzgerald D, Moran N. The platelet integrin αIIbβ3 has an endogenous thiol isomerase activity. J Biol Chem. 2000;275:36984-36990.
17. Burgess JK, Hotchkiss KA, Suter C, et al. Physical proximity and functional association of glycoprotein lba and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem. 2000;275:9758-9766.
18. Essex DW, Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol. 1999;104:448-454.
19. Essex DW, Li M. A polyclonal antibody to protein disulfide isomerase induces platelet aggregation and secretion. Thromb Res. 1999;96:445-450.
20. Essex DW, Li M, Miller A, Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry. 2001;40:6070-6075.
21. Clemetson KJ. Platelet collagen receptors: a new target for inhibition? Haemostasis. 1999;29:16-26.
22. Jung SM, Moroi M. Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin α2β1. J Biol Chem. 2000;275:8016-8026.
23. Siljander PR-M, Farndale RW. Platelet receptors: collagen. In: Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics. Cambridge, United Kingdom: Cambridge University Press; 2002:158-178.
24. Verkleij MW, Morton LF, Knight CG, de Groot PG, Barnes MJ, Sixma JJ. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via α2β1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. Blood. 1998;91:3808-3816.
25. Roest M, Sixma JJ, Wu Y-P, et al. Platelet adhesion to collagen in healthy volunteers is influenced by variation of both α2β1 density and von Willebrand factor. Blood. 2000;96:1433-1437.
26. Nieuwenhuis HK, Sakariassen K, Houdijk WPM, Nievelstein PFEM, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood. 1986;68: 692-695.
27. Kehrel B, Balleisen L, Kokott R, et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood. 1988;71:1074-1078.
28. Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction. Thromb Haemost. 1990;63:74-79.
29. Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet. 1999;353:351-354.
30. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The α2 gene coding sequence T807/A873 of the platelet collagen receptor integrin α2β1 might be a genetic risk factor for the development of stroke in younger patients. Blood. 1999;93:3583-3586.
31. Roest M, Banga JD, Grobbee DE, et al. Homozygosity for 807 T polymorphism in α2 subunit of platelet α2β1 is associated with increased risk of cardiovascular mortality in high-risk women. Circulation. 2000;102:1645-1650.
32. Clemetson JM, Polgar J, Magnenat E, Wells TNC, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcαR and the natural killer receptors. J Biol Chem. 1999;274:29019-29024.
33. Jandrot-Perrus M, Busfield S, Lagrue A-H, et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood. 2000;96:1798-1807.
34. Watson SP. Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost. 1999;82:365-376.
35. Morton LF, Peachey AR, Zijenah LS, Goodall AH, Humphries MJ, Barnes MJ. Conformation-dependent platelet adhesion to collagen involving integrin α2β1-mediated and other mechanisms: multiple α2β 1-recognition sites in collagen type I. Biochem J. 1994;299:791-797.
36. Moroi M, Jung SM, Okuma M, Shynmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445.
37. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J. 1995;306:337-344.
38. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem. 2000;275:35-40.
39. Ernsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin α2β1. Cell. 2000;101:47-56.
40. Knight CG, Morton LF, Onley DJ, et al. Identification in collagen type I of an integrin α2β1-binding site containing an essential GER sequence. J Biol Chem. 1998;273:33287-33294.
41. Zijenah LS, Barnes MJ. Platelet-reactive sites in human collagens I and III: evidence for cell-recognition sites in collagen unrelated to RGD and like sequences. Thromb Res. 1990;59:553-566.
42. Knight CG, Morton LF, Onley DJ, et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res. 1999;41:450-457.
43. Medina V, Kesner L, Stracher A. Purification of non-antibiotic insulinase inhibitors from bacitracin. Biochem Met Metab Biol. 1993;49:255-264.
44. +-dependent binding of collagen by the integrin α2β1 in human platelets. J Biol Chem. 2000;275:24560-24566.
45. Keely PJ, Parise LV. The α2β1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem. 1996;271:26668-26676.
46. Lahav J. Thrombospondin inhibits adhesion of platelets to glass and protein-covered substrata. Blood. 1988;71:1096-1099.
47. Morton LF, Fitzsimmons CM, Rauterberg J, Barnes MJ. Platelet-reactive sites in collagen: collagens I and III possess different aggregatory sites. Biochem J. 1987;248:483-487.
48. Bellavite P, Andrioli G, Guzzo P, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem. 1994;216:444-450.
49. Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem. 1996;271:6586-6589.
50. Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989;264:7576-7583.
51. Fitzsimmons CM, Cawston TE, Barnes MJ. The platelet reactivity of collagen Type I: evidence for multiple platelet-reactive sites in the Type I collagen molecule. Thromb Haemost. 1986;56:95-99.
52. Rogelj S, Reiter KJ, Kesner L, Li M, Essex DW. Enzyme destruction by a protease contaminant in bacitracin. Biochem Biophys Res Commun. 2000;273:829-832.
53. Roth RA. Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem Biophys Res Commun. 1981;98:431-438.
54. Mizunaga T, Katakura Y, Miura T, Maruyama Y. Purification and characterization of yeast protein disulfide isomerase. J Biochem. 1990;108:846-851.
55. Kehrel B, Wierwille S, Clemetson KJ, et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IlIa, and von Willebrand factor do not. Blood. 1998;91:491-499.
56. Coller BS, Scudder LE, Beer J, et al. Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents. Annal N Y Acad Sci. 1991;614:193-213.
57. Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood. 1989;74:182-192.
58. Kaetzel CS, Rao CK, Lamm ME. Protein disulphide-isomerase from human placenta and rat liver: purification and immunological characterization with monoclonal antibodies. Biochem J. 1987;24:39-47.
59. Mandel R, Ryser HJP, Ghani F, Wu M, Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A. 1993;90:4112-4116.
60. Mou Y, Ni H, Wilkins JA. The selective inhibition of β1 and β7 integrin-mediated lymphocyte adhesion by bacitracin. J Immunol. 1998;161:6323-6329.
61. Yan B, Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry. 2001;40:8861-8867.
62. Kamata T, Takada Y. Direct binding of collagen to the I-domain of integrin α2β1 (VLA-2, CD49b/ CD29) in a divalent cation-independent manner. J Biol Chem. 1994;269:26006-26010.
63. Takada Y, Puzon W. Identification of a regulatory region in integrin β1 subunit using activating and inhibiting antibodies. J Biol Chem. 1993;268:17597-17601.
64. Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem. 2000;275:39964-39972.
65. 1 in complex with an Arg-Gly-Asp ligand. Science. 2001;294:339-345.